News

In the trial the drug, an oral endothelin receptor antagonist, met the primary efficacy endpoint of improved exercise capacity, the key secondary endpoint of time to clinical worsening

Immune thrombocytopenic purpura (ITP) is characterized by an immune system malfunction that recognizes the body’s own platelets as foreign and destroys them, potentially resulting in dangerously low platelet

The research indicates that listeria activates the body’s cytotoxic T cells to boost the immune system’s capability to fight cancer cells. Lovaxin C is intended as a treatment

Cethrin has demonstrated neuro-protective and neuro-regenerative properties in vitro as well as in vivo studies suggesting its potential as an effective treatment for acute spinal cord injury. Acute

Results from the study, the largest clinical trial to date for newly diagnosed adult patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, showed that

The follow-up data was taken after nearly six years and demonstrated that the disease did not progress in the patients for an average of 37.7 months after the

The trials will include a comparison of Hana’s nasal spray with GlaxoSmithKline’s Zofran which delivers the same active ingredient in the form of a tablet. A nasal spray

MedImmune’s nasal spray CAIV-T produced a reduction of 55% in influenza illness caused by any influenza strain compared to a standard injectable flu vaccine. 8.6% of the participants

The trial is expected to enroll approximately 370 patients who have not had prior treatment for non small cell lung cancer and who will be randomized into either